Case Report
Donor cell derived acute myeloid leukemia after allogeneic cord blood transplantation in a patient with adult T-cell lymphoma
Article first published online: 25 JUL 2005
DOI: 10.1002/ajh.20349
Copyright © 2005 Wiley-Liss, Inc., A Wiley Company
Additional Information
How to Cite
Matsunaga, T., Murase, K., Yoshida, M., Fujimi, A., Iyama, S., Kuribayashi, K., Sato, T., Kogawa, K., Hirayama, Y., Sakamaki, S., Kohda, K. and Niitsu, Y. (2005), Donor cell derived acute myeloid leukemia after allogeneic cord blood transplantation in a patient with adult T-cell lymphoma. American Journal of Hematology, 79: 294–298. doi: 10.1002/ajh.20349
Publication History
- Issue published online: 25 JUL 2005
- Article first published online: 25 JUL 2005
- Manuscript Accepted: 30 NOV 2004
- Manuscript Received: 6 SEP 2004
- Abstract
- References
- Cited By
Keywords:
- donor cell derived leukemia;
- cord blood transplantation;
- adult T-cell lymphoma
Abstract
We report a patient with adult T-cell lymphoma who developed acute myeloid leukemia (AML) after allogeneic cord blood transplantation (CBT). Fluorescence in situ hybridization (FISH) studies and molecular analysis using short tandem repeat (STR) sequences proved the AML to be of donor origin. Although 25 cases of donor cell leukemia (DCL) occurring after allogeneic bone marrow transplantation have previously been reported, there have been no reports of DCL after CBT. This case is the first-reported DCL patient after CBT. Am. J. Hematol. 79:294–298, 2005. © 2005 Wiley-Liss, Inc.

1096-8652/asset/olbannerleft.gif?v=1&s=d9288d4b31f0b8e9a1eb2d195cb165e0aa1d7a97)
1096-8652/asset/olbannerright.gif?v=1&s=78488ac502104a3d829e729353def6ce62dc1e29)
1096-8652/asset/cover.gif?v=1&s=d31a603f9c7a1894ee3b68044c6fdcbe64ff8068)